Christina Smolke is an American synthetic biologist, serving as the CEO and Cofounder of Antheia Bio and as a Full Professor of Bioengineering and Chemical Engineering at Stanford University. Her primary research focuses on utilizing yeast to produce opioids for medical applications. She pursued her education at the California Institute of Technology and Stanford University, aiming to program cells to synthesize complex molecules through 50-100 enzymatic steps.